Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC) Meeting Abstract
| Authors: | Autio, K. A.; Antonarakis, E. S.; Baser, R.; Stein, M. N.; Shevrin, D. H.; Vaishampayan, U. N.; Mayer, T. M.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; Tagawa, S. T.; Rathkopf, D. E.; Milowsky, M. I.; Harrison, M. R.; Beer, T. M.; Balar, A. V.; Armstrong, A. J.; Paller, C. J.; Basch, E. M.; Scher, H. I. |
| Abstract Title: | Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 307s |
| Language: | English |
| ACCESSION: | WOS:000487345805487 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.5080 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5080 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
